Stockreport

Edgewise's EDG-7500 shows benefit in two obstructive HCM trials [Yahoo! Finance]

Edgewise Therapeutics, Inc.  (EWTX) 
PDF where its EDG-7500 showed benefit as a potential treatment for obstructive hypertrophic cardiomyopathy (HCM). The data comprise results from a Phase I trial in healthy [Read more]